Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Eton Pharmaceutcials Inc (ETON)

Eton Pharmaceutcials Inc (ETON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin injection) GlobeNewswire - Fri Dec 20, 5:50AM CST

ETON : 12.57 (+2.36%)
Eton Pharmaceuticals Announces Final Readout of PKU GOLIKE® Clinical Trial GlobeNewswire - Tue Dec 17, 5:50AM CST

ETON : 12.57 (+2.36%)
Eton Pharmaceuticals Appoints Ipek Erdogan-Trinkaus as Chief Commercial Officer Quiver Quantitative, Inc. - Tue Dec 3, 4:16PM CST

Eton Pharmaceuticals appointed Ipek Erdogan-Trinkaus as Chief Commercial Officer, leveraging her extensive pharmaceutical sales and marketing expertise.Quiver AI SummaryEton Pharmaceuticals, Inc. has appointed...

ETON : 12.57 (+2.36%)
Eton Pharmaceuticals Appoints Ipek Erdogan-Trinkaus as Chief Commercial Officer GlobeNewswire - Tue Dec 3, 5:50AM CST

ETON : 12.57 (+2.36%)
ETON
Eton Pharma - Small Cap That's Climbing Barchart - Tue Nov 26, 7:00AM CST

Summary Eton Pharmaceuticals (ETON) has shown exceptional price appreciation, gaining 224.93% since a Trend Seeker buy signal on 7/17, supported by strong technical indicators. The company focuses on developing...

ETON : 12.57 (+2.36%)
Eton Pharmaceuticals Acquires U.S. Rights to Amglidia® for Neonatal Diabetes Treatment Following EMA Approval Quiver Quantitative, Inc. - Mon Nov 25, 4:16PM CST

Eton Pharmaceuticals acquires U.S. rights to Amglidia, approved in Europe for neonatal diabetes mellitus, aiming for 2026 FDA submission.Quiver AI SummaryEton Pharmaceuticals has acquired the U.S. rights...

ETON : 12.57 (+2.36%)
Eton Pharmaceuticals Announces Acquisition of U.S. Rights to Amglidia (Glyburide Oral Suspension) GlobeNewswire - Mon Nov 25, 5:50AM CST

ETON : 12.57 (+2.36%)
Eton Pharmaceuticals Reports Third Quarter 2024 Financial Results GlobeNewswire - Tue Nov 12, 3:01PM CST

ETON : 12.57 (+2.36%)
Eton Pharmaceuticals Awarded Second Patent for ET-400 (Hydrocortisone Oral Solution) GlobeNewswire - Thu Nov 7, 6:00AM CST

ETON : 12.57 (+2.36%)
Eton Pharmaceuticals to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024 GlobeNewswire - Wed Nov 6, 3:30PM CST

ETON : 12.57 (+2.36%)

Barchart Exclusives

Love Dividends? 2 Passive Income Stocks to Scoop Up Now. Barchart - 23 minutes ago
These consistent dividend-paying stocks could be a good addition to your portfolio. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot